The article expresses skepticism about Clene's ALS treatment, CNM-Au8, which is essentially a liquid gold supplement, questioning its efficacy as a cure for the disease. The author highlights the dubious nature of using gold microdust in a therapeutic context.
The article raises skepticism about Clene's ALS treatment, CNM-Au8, which involves gold microdust suspended in water, highlighting the importance of critically evaluating the scientific basis and clinical evidence behind biotech innovations before considering investment or adoption. This underscores the need for professionals in healthtech and biotech to carefully scrutinize the legitimacy and efficacy of novel treatments, especially those with unconventional approaches, to make informed decisions.